Special Issue "Receptor Tyrosine Kinases"

Quicklinks

A special issue of Cells (ISSN 2073-4409).

Deadline for manuscript submissions: closed (15 November 2013)

Special Issue Editor

Guest Editor
Dr. Sassan Hafizi
School of Pharmacy and Biomedical Sciences, Division of Pharmacology, University of Portsmouth, St. Michael's Building, White Swan Road, Portsmouth PO1 2DT, UK
Website: http://www.port.ac.uk/institute-of-biomedical-and-biomolecular-science/cell-biology-and-pharmacology/sassan-hafizi/
E-Mail: sassan.hafizi@port.ac.uk
Phone: +44 0 2392 842665
Fax: +44 0 2392 843565
Interests: epigenetics; focal adhesion proteins; receptor tyrosine kinases; cell signalling; vitamin K; cancer; myelin; multiple sclerosis; brain tumours; renal carcinoma; cytoskeleton; cell migration

Special Issue Information

Dear Colleagues,

Since the earliest discoveries of growth factors in the 1950s and of transmembrane receptors for these factors that possess protein tyrosine kinase activity in the 1970s, the body of knowledge on receptor tyrosine kinases (RTKs) has increased appreciably. The uniqueness in structure and ligand-binding specificities of the ectodomain of RTKs determines their subclassification, and today we know of the existence of around 20 different RTK classes, with a number and diversity of ligands that is ever increasing. Despite this diversity, RTKs continue to together represent a major group of molecules that play important roles in both health and disease. Normal RTK function is associated with development, cell and tissue growth and differentiation and cell-cell and cell-matrix interaction, whereas RTK overactivity and/or overexpression is a common feature in many cancers. However, novel aspects to RTK structure and function are increasingly becoming apparent as more research is being done. Amongst these include ligand-dependent and -independent mechanisms of activation, alternative and unexpected receptor clustering patterns, spatial and temporal control of RTK signalling, intracellular RTK functions, RTKs as entry gateways for pathogens, and as highly attractive candidates in target-specific cancer therapy. The aim with this Special Issue of Cells is to offer an Open Access collection of scholarly reviews on the forefront of research on RTKs that covers all of the above aspects and more. We hope to provide a stimulating resource that will inform the student and the academic on the breadth and diversity of RTK biology. This is a field that is sure to maintain a high level of interest and research activity from both academic and industrial sectors with interests in science and medicine well into the future.

Dr. Sassan Hafizi
Guest Editor

Submission

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. Papers will be published continuously (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are refereed through a peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed Open Access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 500 CHF (Swiss Francs). English correction and/or formatting fees of 250 CHF (Swiss Francs) will be charged in certain cases for those articles accepted for publication that require extensive additional formatting and/or English corrections.


Keywords

  • receptor tyrosine kinases
  • growth factor
  • signal transduction
  • phosphorylation
  • spatial and temporal signalling
  • tyrosine kinase domain
  • transmembrane domain
  • RTK class
  • dimerisation
  • docking protein
  • development
  • differentiation
  • cancer
  • monoclonal antibodies
  • small molecule inhibitors
  • anti-cancer drug resistance

Published Papers (9 papers)

Download All Papers
Sort by:
Display options:
Select articles Export citation of selected articles as:
Select/unselect all
Displaying article 1-9
p. 657-659
by
Cells 2014, 3(2), 657-659; doi:10.3390/cells3020657
Received: 11 June 2014; Accepted: 12 June 2014 / Published: 20 June 2014
Show/Hide Abstract | PDF Full-text (143 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Receptor Tyrosine Kinases)
p. 563-591
by , , , , , , ,  and
Cells 2014, 3(2), 563-591; doi:10.3390/cells3020563
Received: 31 March 2014; in revised form: 14 May 2014 / Accepted: 19 May 2014 / Published: 10 June 2014
Show/Hide Abstract | Cited by 1 | PDF Full-text (1568 KB) | HTML Full-text | XML Full-text | Supplementary Files
(This article belongs to the Special Issue Receptor Tyrosine Kinases)
abstract graphic
p. 363-385
by , , , , , , ,  and
Cells 2014, 3(2), 363-385; doi:10.3390/cells3020363
Received: 2 December 2013; in revised form: 4 March 2014 / Accepted: 17 March 2014 / Published: 29 April 2014
Show/Hide Abstract | Cited by 2 | PDF Full-text (1278 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Receptor Tyrosine Kinases)
p. 304-330
by
Cells 2014, 3(2), 304-330; doi:10.3390/cells3020304
Received: 6 March 2014; in revised form: 10 April 2014 / Accepted: 11 April 2014 / Published: 22 April 2014
Show/Hide Abstract | Cited by 3 | PDF Full-text (297 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Receptor Tyrosine Kinases)
p. 199-235
by ,  and
Cells 2014, 3(2), 199-235; doi:10.3390/cells3020199
Received: 18 December 2013; in revised form: 12 March 2014 / Accepted: 21 March 2014 / Published: 4 April 2014
Show/Hide Abstract | Cited by 2 | PDF Full-text (398 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Receptor Tyrosine Kinases)
p. 129-149
by , ,  and
Cells 2014, 3(1), 129-149; doi:10.3390/cells3010129
Received: 11 December 2013; in revised form: 11 February 2014 / Accepted: 12 February 2014 / Published: 19 February 2014
Show/Hide Abstract | Cited by 4 | PDF Full-text (502 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Receptor Tyrosine Kinases)
abstract graphic
p. 92-111
by , , ,  and
Cells 2014, 3(1), 92-111; doi:10.3390/cells3010092
Received: 22 November 2013; in revised form: 7 February 2014 / Accepted: 7 February 2014 / Published: 14 February 2014
Show/Hide Abstract | Cited by 1 | PDF Full-text (793 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Receptor Tyrosine Kinases)
abstract graphic
p. 53-78
by ,  and
Cells 2014, 3(1), 53-78; doi:10.3390/cells3010053
Received: 25 November 2013; in revised form: 14 January 2014 / Accepted: 20 January 2014 / Published: 27 January 2014
Show/Hide Abstract | Cited by 2 | PDF Full-text (529 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Receptor Tyrosine Kinases)
abstract graphic
p. 751-767
by , , ,  and
Cells 2013, 2(4), 751-767; doi:10.3390/cells2040751
Received: 29 October 2013; in revised form: 19 November 2013 / Accepted: 27 November 2013 / Published: 6 December 2013
Show/Hide Abstract | Cited by 1 | PDF Full-text (488 KB) | HTML Full-text
(This article belongs to the Special Issue Receptor Tyrosine Kinases)
abstract graphic
Select/unselect all
Displaying article 1-9
Select articles Export citation of selected articles as:

Planned Papers

The below list represents only planned manuscripts. Some of these manuscripts have not been received by the Editorial Office yet. Papers submitted to MDPI journals are subject to peer-review.

Last update: 10 June 2014

Cells EISSN 2073-4409 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert